Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Effects of Nasal High Flow Therapy as a Treatment Option for Patients With Respiratory Insufficiencies During Sleep.

NCT02152566 is registered in ClinicalTrials.gov with Fisher and Paykel Healthcare as lead sponsor.

NCT NCT02152566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02152566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Effects of Nasal High Flow Therapy as a Treatment Option for Patients With Respiratory Insufficiencies During Sleep.
Lead sponsor
Fisher and Paykel Healthcare
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2014
Completion date
August 31, 2014
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, sleep disordered breathing